Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Giovanni, Furlan"'
Autor:
Elisa Baratella, Stefano Cernic, Pierluca Minelli, Giovanni Furlan, Filippo Crimì, Simone Rocco, Barbara Ruaro, Maria Assunta Cova
Publikováno v:
Tomography, Vol 8, Iss 6, Pp 2828-2838 (2022)
Background: Lung cancer represents a heterogeneous group of neoplasms, with the highest frequency and mortality in both sexes combined. In a clinical scenario characterized by the widespread of multidetector-row spiral CT, core-needle biopsy under to
Externí odkaz:
https://doaj.org/article/37f8ab1665c544e9bc0068a182abd163
Autor:
Marco Sardella, Glyn Belcher, Calin Lungu, Terenzio Ignoni, Manuela Camisa, Doris Irene Stenver, Paolo Porcelli, Margherita D’Antuono, Nicola Gian Castiglione, Anna Adams, Giovanni Furlan, Ilaria Grisoni, Sarah Hall, Laura Boga, Valentina Mancini, Mircea Ciuca, David Chonzi, Brian Edwards, Arduino A Mangoni, Marco Tuccori, Elena Prokofyeva, Fabio De Gregorio, Mario Bertazzoli Grabinski Broglio, Bert van Leeuwen, Paola Kruger, Christian Rausch, Hervé Le Louet
Publikováno v:
Therapeutic Advances in Drug Safety, Vol 12 (2021)
The collection and assessment of individual case safety reports (ICSRs) is important to detect unknown adverse drug reactions particularly in the first decade after approval of new chemical entities. However, regulations require that these activities
Externí odkaz:
https://doaj.org/article/e2f577c0d23646f1bd9f7bce36bd7551
Autor:
Priya Bahri, Geoffrey Bowring, Brian D. Edwards, Christopher Anton, Jeffrey K. Aronson, Angela Caro-Rojas, Bruce P. J. Hugman, Peter G. Mol, Gianluca Trifirò, Katarina Ilic, Riadh Daghfous, Irene Fermont, Giovanni Furlan, Wolfgang Gaissmaier, Mohammad Ishaq Geer, Kenneth Y. Hartigan-Go, François Houÿez, Hansjörg Neth, Gediminas Norgela, Yaowares Oppamayun, D. K. Theo Raynor, Mehdi Bouhlel, Federica Santoro, Janet Sultana
published
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::421cbd69563689a8e3886412d9e13ad2
Autor:
Giovanni Furlan
Publikováno v:
Festival dell'Architettura Magazine, Vol 0, Iss 43, Pp 99-100 (2018)
Book Review Title: Eutopia Urbana / Eutopia Urbanscape Subtitle: La riqualificazione integrata dell'edilizia sociale / The combined redevelopment of social housing Language: Italian / English Publisher: LetteraVentidue, Siracusa Edited by: Barbara A
Externí odkaz:
https://doaj.org/article/3bd12cdd4dd64e77828d8f9e92ea58fe
Autor:
David Power, Giovanni Furlan
Publikováno v:
Pharmaceutical Medicine. 34:369-380
Patients and prescribers need to be aware of adverse drug events to minimize the risk of their occurrence and the severity with which they appear. However, numerous studies show that being informed about adverse events can increase the possibility of
Autor:
Fabio De Gregorio, Arduino A. Mangoni, Giovanni Furlan, Terenzio Ignoni, Marco Tuccori, Hervé Le Louet, Bert van Leeuwen, Nicola Gian Castiglione, Manuela Camisa, Marco Sardella, Anna L. Adams, Paolo Porcelli, Doris Irene Stenver, Glyn Belcher, Elena Prokofyeva, Valentina Mancini, Brian Edwards, Ilaria Grisoni, Mircea Ciuca, Mario Bertazzoli Grabinski Broglio, Margherita D'Antuono, David Chonzi, Laura Boga, Calin Lungu, Christian Rausch, Paola Kruger, Sarah Hall
Publikováno v:
Therapeutic Advances in Drug Safety, Vol 12 (2021)
Therapeutic Advances in Drug Safety
Therapeutic Advances in Drug Safety
The collection and assessment of individual case safety reports (ICSRs) is important to detect unknown adverse drug reactions particularly in the first decade after approval of new chemical entities. However, regulations require that these activities
Autor:
Laura Sottosanti, G Valdiserra, Giovanni Furlan, E Cappello, Marco Tuccori, Pia Caduff-Janosa
Publikováno v:
Drug safety. 43(9)
Elderly patients are the main users of drugs and they differ from younger patients. They are a heterogeneous population that cannot be defined only by age but should rather be stratified based on their frailty. The elderly have distinctive pharmacoki
Publikováno v:
Pharmaceutical Medicine. 31:75-80
Over the last approximately 20 years, the pharmaceutical industry has increasingly outsourced its research and development activities, including pharmacovigilance, with mixed results. To avoid significant failures, both clients and service providers
Autor:
Loro, Daniele, Fava, Ferdinando, Visentin, Michele, Girardi, Davide, Toppan, Paola, Bon, Giuseppe, Cattaneo, Paola, Grassi, Angela, REALDI Giovanni, FURLAN Davide.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1943::7992704f3d7d8f8cebf581db76dab574
http://hdl.handle.net/11562/1017110
http://hdl.handle.net/11562/1017110